André C. Carpentier
Université de Sherbrooke · Centre de recherche clinique du Centre hospitalier universitaire de Sherbrooke
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name André C. Carpentier as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:14 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07133854 · How Abnormal Function of Fat Tissue in Type 1 Diabetes Contributes to Fat in the LiverUniversité de Sherbrooke · not yet recruiting · Metabolic Dysfunction-Associated Steatotic Liver Disease, Non-Alcoholic Steato-Hepatitis (NASH), Type 1 Diabetes Mellitus
- N/ANCT05553184 · Activation of Brown Adipose Tissue Thermogenesis in Humans Using Formoterol Fumarate (GB10)Université de Sherbrooke · completed · Type 2 Diabetes, Obesity · principal investigator
- N/ANCT03298009 · Impact of a Short-term Treatment With Canagliflozin (Canacardia-HF)Université de Sherbrooke · withdrawn · Type2 Diabetes, Heart Failure · principal investigator
- N/ANCT03188835 · Effects of Fructose/Glucose-rich Diet on Brown Fat in Healthy Subjects (GB7)Université de Sherbrooke · completed · Type2 Diabetes · principal investigator
- N/ANCT00306449 · Prevention of Weight Gain in Young AdultsUniversité de Sherbrooke · completed · Weight Gain, Obesity, Overweight · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:14 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:14 UTC. The ranking covers the 200 most relevant of 19 PubMed records, and a shared surname and initials can bring in a namesake. All 19 on PubMed
- Increased brown adipose tissue oxidative capacity in cold-acclimated humans.J Clin Endocrinol Metab · 2014254 citationsRCR 8.8
- Inhibition of Intracellular Triglyceride Lipolysis Suppresses Cold-Induced Brown Adipose Tissue Metabolism and Increases Shivering in Humans.Cell Metab · 2017166 citationsRCR 6.3
- Effect of alipogene tiparvovec (AAV1-LPL(S447X)) on postprandial chylomicron metabolism in lipoprotein lipase-deficient patients.J Clin Endocrinol Metab · 2012127 citationsRCR 3.4
- Limited recovery of β-cell function after gastric bypass despite clinical diabetes remission.Diabetes · 201475 citationsRCR 2.4
- Prevention of weight gain in young adults through a seminar-based intervention program.Int J Obes (Lond) · 200769 citationsRCR 2.1
- 47 citationsRCR 1.7
- Plasma Palmitoyl-Carnitine (AC16:0) Is a Marker of Increased Postprandial Nonesterified Incomplete Fatty Acid Oxidation Rate in Adults With Type 2 Diabetes.Can J Diabetes · 201826 citationsRCR 1.3
- L-T3 preparation for whole-body scintigraphy: a randomized-controlled trial.Clin Endocrinol (Oxf) · 200725 citationsRCR 0.8
- A cost-effective moderate-intensity interdisciplinary weight-management programme for individuals with prediabetes.Diabetes Metab · 201125 citationsRCR 0.8
- Improved cardiac function and dietary fatty acid metabolism after modest weight loss in subjects with impaired glucose tolerance.Am J Physiol Endocrinol Metab · 201425 citationsRCR 0.8